India Investigates Substandard Batch of Abhayrab Rabies Vaccine

Indian regulatory authorities have identified a batch of the Abhayrab rabies vaccine as substandard and initiated an investigation to determine if the product is counterfeit. Health officials are reviewing distribution records and safety protocols following the discovery.